Pilot evaluation of paroxetine for treating hot flashes in men

Mayo Clinic Proceedings

Volumn 79, Issue 10, 2004, Pages 1247-1251

  Loprinzi, Charles L ^a   Barton, Debra L ^a   Carpenter, Lisa A ^a   Sloan, Jeff A ^a   Novotny, Paul J ^a   Gettman, Matthew T ^a   Christensen, Bradley J ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HOT FLUSH; HUMAN; MALE; PILOT STUDY; PROSTATE CANCER; QUALITY OF LIFE; SIDE EFFECT;

EID: 4644308164     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.10.1247     Document Type: Article

References (25)

1. Schow DA, Renfer LG, Rozanski TA, Thompson IM. Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer. South Med J. 1998;91:855-857.
2. Charig CR, Rundle JS. Flushing: long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology. 1989;33:175-178.
3. Clark JA, Wray N, Brody B, Ashton C, Giesler B, Watkins H. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med. 1997;45:1299-1309.
4. Quella S, Loprinzi CL, Dose AM. A qualitative approach to defining "hot flashes" in men. Urol Nurs. 1994;14:155-158.
5. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 1994;331:347-352.
6. Burch PA, Loprinzi CL. Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate [letter]. J Clin Oncol. 1999;17:1087-1088.
7. Loprinzi CL, Pisansky TM, Fonseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol. 1998;16:2377-2381.
8. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356:2059-2063.
9. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol. 2000;11:17-22.
10. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003;289:2827-2834.
11. Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology. 1998;7:129-132.
12. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280-4290.
13. Quella SK, Loprinzi CL, Sloan J, et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol. 1999;162:98-102.
14. Barton D, Loprinzi C, Quella S, Sloan J, Pruthi S, Novotny P. Depomedroxyprogesterone acetate for hot flashes. J Pain Symptom Manage. 2002;24:603-607.
15. Loprinzi CL, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc. 2002;77:1159-1163.
16. Barton DL, Loprinzi CL, Novotny P, et al. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003;1:47-51.
17. Curran SL, Andrykowski MA, Studts JL. Short Form of the Profile of Mood States (POMS-SF): psychometric information. Psycho Assess. 1995;7:80-83.
18. Sloan JA, O'Fallon JR, Suman VJ, et al. Incorporating quality of life measurement in oncology clinical trials. Proc Am Stat Assoc. 1998;282-287.
19. Pockaj B, Loprinzi C, Sloan J, et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. In press.
20. Perez DG, Loprinzi CL, Barton DL, et al. Pilot evaluation of mirtazapine for the treatment of hot flashes. J Support Oncol. 2004;2:50-56.
21. Miller JI, Ahmann FR. Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer. Urology. 1992;40:499-502.
22. Atala A, Amin M, Harty JI. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone. Urology. 1992;39:108-110.
23. Loprinzi CL, Goldberg RM, O'Fallon JR, et al. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994;151:634-636.
24. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published correction appears in J Clin Oncol. 1996;14:2411]. J Clin Oncol. 1994;12:155-158.
25. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published correction appears in J Clin Oncol. 1996;14:2411]. J Clin Oncol. 1994;12:155-158.